Shareholder's Lament......., page-5

I don't know that credibility is shot Scooter, I just think they should have had some follow up action
well and truly sorted out to keep market interest.......
It really is blatantly obvious now that PRR simply haven't the funding to proceed
with CAN trials to the next level......I get that and as the saying goes "that's biotech".
With the acquisition of Immuteps Lag-3 research, thankfully there could be an alternative.....
But where is the promotion from the company?
SR is doing a great job in my opinion but let's face it his emails do not reach everyone....
I hope something comes out shortly, it doesn't have to be market sensitive,
but it goes without saying they really need to reinforce to the market their
reasons for changing tack.....Silence will not do that....